跳至主要内容
临床试验/NCT02600559
NCT02600559已完成3 期

An 8-Week, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Administration in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes

Otonomy, Inc.1 个研究点 分布在 1 个国家目标入组 501 人开始时间: 2015年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Otonomy, Inc.
入组人数
501
试验地点
1
主要终点
Number of Subjects With Post-surgical Otorrhea

研究概览

简要总结

This is an 8-week, multicenter, open-label study in which eligible subjects with a history of otitis media requiring TT placement will receive 6 mg OTO-201 to each ear. The study is designed to evaluate the safety and efficacy of OTO-201 in subjects undergoing TT placement with common concurrent surgeries and any middle ear effusion status.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Months 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

0.1 mL OTO-201

Experimental

Ciprofloxacin

干预措施: OTO-201 (ciprofloxacin) (Drug)

结局指标

主要结局

Number of Subjects With Post-surgical Otorrhea

时间窗: 8 weeks

Absence or presence of otorrhea (drainage from the middle ear)

次要结局

  • Adverse Events(Up to Eight Weeks)
  • Caregiver Burden - Ear Drops Administration(Week 8)
  • Caregiver Burden - Ear Discharge Control(Week 8)

研究者

发起方
Otonomy, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Open-Label Study of OTO-201 in Pediatric Subjects... | 临床试验